Elevated serum osteopontin levels in patients with severe cutaneous adverse drug reactions. Suzuki M, Koshikawa S, Watanabe H, Inomata N, et al. J Dermatol 2022 Dec 20. doi: 10.1111/1346-8138.16670.

Read + Share

Amedeo Smart

Independent Medical Education

Suzuki M, Koshikawa S, Watanabe H, Inomata N, et al. Elevated serum osteopontin levels in patients with severe cutaneous adverse drug reactions. J Dermatol 2022 Dec 20. doi: 10.1111/1346-8138.16670.
PMID: 36540013